MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR

BACKGROUND: Triple-negative breast cancer (TNBC) is highly aggressive with an increased metastatic incidence compared to other breast cancer subtypes. However, due to the absence of clinically reliable biomarkers and targeted therapy in TNBC, outcomes are suboptimal. Hence, there is an urgent need t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Sanjib, Appadurai, Muthamil Iniyan, Maurya, Shailendra Kumar, Nallasamy, Palanisamy, Marimuthu, Saravanakumar, Shah, Ashu, Atri, Pranita, Ramakanth, Chirravuri Venkata, Lele, Subodh M., Seshacharyulu, Parthasarathy, Ponnusamy, Moorthy P., Nasser, Mohd W., Ganti, Apar Kishor, Batra, Surinder K., Lakshmanan, Imayavaramban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012760/
https://www.ncbi.nlm.nih.gov/pubmed/36918912
http://dx.doi.org/10.1186/s13058-023-01630-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012760/
https://www.ncbi.nlm.nih.gov/pubmed/36918912
http://dx.doi.org/10.1186/s13058-023-01630-7

Ejemplares similares